Introduction

The Indian pharmaceuticals market is Large Market with Some of the Leading Giants covering a big part of that market whereas PCD companies all together share a small part of it in an unorganized manner. Prector Lifesciences is offering you PCD Franchise opportunity with a different vision to Organize this sector and be a leader of the market.

Market Size

The Indian pharmaceuticals market is the third largest in terms of volume and thirteenth largest in terms of value, and it accounts for 20 per cent in the volume terms and 1.4 per cent in value terms of the Global Pharmaceutical Industry as per a report by Equity Master. India enjoys an important position in the global pharmaceuticals sector and lots of new Opportunities with Digitization.

Government Initiatives

The implementation of the Goods and Services Tax (GST) is expected to be a game-changer for the Indian Pharmaceuticals industry. It will lead to tax-neutral inter-state transactions between two dealers, thereby reducing the dependency on multiple states and increasing the focus on regional hubs. It is expected to result in an efficient supply chain management, which is expected to reduce its cost considerably.

Road Ahead

The Indian pharmaceutical market size is expected to grow to US$ 100 billion by 2025, driven by increasing consumer spending, rapid urbanisation, and raising healthcare insurance among others.

We at PRECTOR LIFESCIENCES, look forward to a better growth in domestic sales by connecting Customer, Doctor and Franchise Together.

Contact Information:

To know more about PRECTOR LIFESCIENCES, contact at +91-9569858585 or drop a mail at enquiry@prectorlife.com